Free Trial
NASDAQ:RVPHW

Reviva Pharmaceuticals (RVPHW) Stock Price, News & Analysis

$0.22 -0.01 (-6.48%)
(As of 01:59 PM ET)

About Reviva Pharmaceuticals Stock (NASDAQ:RVPHW)

Key Stats

Today's Range
$0.18
$0.22
50-Day Range
$0.09
$0.29
52-Week Range
$0.07
$1.62
Volume
2,615 shs
Average Volume
16,128 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company was founded in 2018 and is based in Cupertino, California.

Receive RVPHW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

RVPHW Stock News Headlines

Reviva announces enrollment update for OLE study of brilaroxazine
Reviva Pharmaceuticals Progresses with Brilaroxazine Study Update
Top investors are backing this “unlisted” stock
When the team that built Zillow into a $16B real estate leader launches a new company, it’s worth paying attention. That’s why top firms like SoftBank and Maveron have already backed their latest venture, a company that’s transforming the $1.3 trillion vacation home market.
RVPH: RECOVER Biomarker KOL Event
See More Headlines

RVPHW Stock Analysis - Frequently Asked Questions

Reviva Pharmaceuticals' stock was trading at $1.43 at the beginning of 2024. Since then, RVPHW shares have decreased by 85.0% and is now trading at $0.2150.
View the best growth stocks for 2024 here
.

Shares of RVPHW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:RVPHW
Web
N/A
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:RVPHW) was last updated on 11/29/2024 by MarketBeat.com Staff
From Our Partners